Wait a sec­ond. J&J is back in the bid­ding for Acte­lion, el­bow­ing Sanofi aside

One minute re­porters for Bloomberg and Reuters are telling you that the Sanofi $SNY takeover talks with Acte­lion $ATLN are pro­gress­ing nice­ly, and the next minute Sanofi is out and J&J is back in.

Just sev­en days af­ter J&J for­mal­ly said it was push­ing away from the deal ta­ble and drop­ping an ef­fort to buy Acte­lion, the phar­ma gi­ant now has en­tered in­to “ex­clu­sive ne­go­ti­a­tions” with the Swiss biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER